FASN and cancer: O-GlcNac production may be directly modulated by nutrient flux and intracellular metabolism [36]; however, the impact of de novo lipogenesis via FASN upregulation on hexosamine metabolism-associated enzymes and O-linked protein glycosylation in cancer cells has not been reported.